Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Many congratulations to all our finalists for 2022. We have seen an incredible number of worthy entrants which made the judging process extremely hard.
Here is the full shortlist:
Best New Drug – Sponsored by CMIC
Astellas’ Padcev (enfortumab vedotin) for urothelial carcinoma
Fujifilm Toyama Chemical’s Lutathera (lutetium oxodotreotide) for neuroendocrine tumors
JCR Pharma’s Izcargo (pabinafusp alfa) for mucopolysaccharidosis type II
Otsuka Pharm’s Moizerto (difamilast) for atopic dermatitis
Sanwa Kagaku’s Upasita (upacicalcet sodium hydrate) for secondary hyperparathyroidism in hemodialysis patients
Takeda’s Alofisel (darvadstrocel) for complex perianal fistulas in Crohn’s disease
Takeda’s Revestive (teduglutide) for short bowel syndrome
Executive of the Year
Chris Cargill, executive officer, chief financial officer, Sosei Heptares (this relates to his position at the time of nomination)
Hiroshi Kawamoto, director, Rebirthel, and professor, Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University
Tetsuhito Matsuyama, president and CEO, NanoCarrier
Daisuke Morishita, co-founder and chief scientific officer, Chordia Therapeutics
Kazuo Nakamura, chairman and CEO, CMIC Group
Biotech Company of the Year – Private
ARTham Therapeutics
Chordia Therapeutics
Cuorips
Heartseed
Prism BioLab
Rebirthel
ReboRNA Biosciences
TMS
Biotech Company of the Year – Public
NanoCarrier
Rakuten Medical (Rakuten Group Inc.’s equity accounted affiliate)
Sosei Heptares
Stella Pharma
StemCell Institute
Licensing Deal of the Year
Asahi Kasei Pharma with Lilly for chronic pain candidate AK1780
Heartseed with Novo Nordisk for heart failure candidate HS-001
Rebirthel with Otsuka Pharmaceutical for iPSC-derived CAR-T/TCR-T therapies
ReboRNA Biosciences’ research collaboration/option deal with Biogen for CNS disorders
Sosei Heptares with Neurocrine Biosciences for novel muscarinic receptor agonists
Best Contract Research Organization
Avance Clinical
Calyx
CMIC Group
EPS
ICON
Parexel
Syneos Health
Pharma Company of the Year
Daiichi Sankyo
Shionogi
Takeda
Lifetime Achievement Award – sponsored by ICON
Winner will be announced on the night
